|
|||||
|
|
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents |
|
| Authors: | Genovese Mark C Kavanaugh Arthur Weinblatt Michael E Peterfy Charles DiCarlo Julie White Michael L O'Brien Maryann Grossbard Elliott B Magilavy Daniel B |
| Affiliation: | Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. genovese@stanford.edu |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |